Merging Passivation in Synthesis Enabling the Lowest Open-Circuit Voltage Loss for PbS Quantum Dot Solar Cells

Bibliographische Detailangaben
Veröffentlicht in:	Advanced materials (Deerfield Beach, Fla.). - 1998. - 35(2023), 5 vom: 15. Feb., Seite e2207293
1. Verfasser:	Liu, Yang (VerfasserIn)
Weitere Verfasser:	Wu, Hao, Shi, Guozheng, Li, Yusheng, Gao, Yiyuan, Fang, Shiwen, Tang, Haodong, Chen, Wei, Ma, Tianshu, Khan, Irfan, Wang, Kai, Wang, Changlei, Li, Xiaofeng, Shen, Qing, Liu, Zeke, Ma, Wanli
Format:	Online-Aufsatz
Sprache:	English
Veröffentlicht:	2023
Zugriff auf das übergeordnete Werk:	Advanced materials (Deerfield Beach, Fla.)
Schlagworte:	Journal Article Voc loss colloidal quantum dots functional molecules passivation solar cells

Beschreibung
Zusammenfassung:	© 2022 Wiley-VCH GmbH. The high open-circuit voltage (Voc ) loss arising from insufficient surface passivation is the main factor that limits the efficiency of current lead sulfide colloidal quantum dots (PbS CQDs) solar cell. Here, synergistic passivation is performed in the direct synthesis of conductive PbS CQD inks by introducing multifunctional ligands to well coordinate the complicated CQDs surface with the thermodynamically optimal configuration. The improved passivation effect is intactly delivered to the final photovoltaic device, leading to an order lower surface trap density and beneficial doping behavior compared to the control sample. The obtained CQD inks show the highest photoluminescence quantum yield (PLQY) of 24% for all photovoltaic PbS CQD inks, which is more than twice the reported average PLQY value of ≈10%. As a result, a high Voc of 0.71 V and power conversion efficiency (PCE) of 13.3% is achieved, which results in the lowest Voc loss (0.35 eV) for the reported PbS CQD solar cells with PCE >10%, comparable to that of perovskite solar cells. This work provides valuable insights into the future CQDs passivation strategies and also demonstrates the great potential for the direct-synthesis protocol of PbS CQDs
Beschreibung:	Date Completed 03.02.2023 Date Revised 03.02.2023 published: Print-Electronic Citation Status PubMed-not-MEDLINE
ISSN:	1521-4095
DOI:	10.1002/adma.202207293